Pioglitazone increases non-esterified fatty acid clearance in upper body obesity

Diabetologia

Volumn 49, Issue 1, 2006, Pages 149-157

  Shadid, S ^a,b,c   Jensen, M D ^a  

^a MAYO CLINIC   (United States)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c VIECURI MEDICAL CENTER   (Netherlands)

Author keywords

3H Oleate; Diet exercise; Glucose; Insulin resistance

Indexed keywords

FATTY ACID; GLUCOSE; OLEIC ACID; PIOGLITAZONE; SODIUM CHLORIDE;

ADIPOSE TISSUE; ADULT; ANGIONEUROTIC EDEMA; ARTICLE; CALORIMETRY; CLINICAL ARTICLE; CONTROLLED STUDY; DIET; EXERCISE; FEMALE; GLYCEMIC CONTROL; HUMAN; HUMAN TISSUE; INFUSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; KINETICS; LIPID METABOLISM; LIPOLYSIS; MALE; MEASUREMENT; OBESITY; OXIDATION; PRIORITY JOURNAL; VOLUNTEER;

ADULT; BODY MASS INDEX; BODY WEIGHT; DIET, REDUCING; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; OBESITY; SEX CHARACTERISTICS; THIAZOLIDINEDIONES;

EID: 31444452779     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-005-0051-0     Document Type: Article

References (45)

1. Evans DJ, Hoffmann RG, Kalkhoff RK, Kissebah AH (1984) Relationship of body fat topography to insulin sensitivity and metabolic profiles in premenopausal women. Metabolism 33:68-75
2. Peiris AN, Struve MF, Mueller RA, Lee MB, Kissebah AH (1988) Glucose metabolism in obesity: influence of body fat distribution. J Clin Endocrinol Metab 67:760-767
3. Jensen MD, Haymond MW, Rizza RA, Cryer PE, Miles JM (1989) Influence of body fat distribution on free fatty acid metabolism in obesity. J Clin Invest 83:1168-1173
4. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E et al (1989) Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84:205-213
5. Basu A, Basu R, Shah P, Vella A, Rizza RA, Jensen MD (2001) Systemic and regional free fatty acid metabolism in type 2 diabetes. Am J Physiol Endocrinol Metab 280:E1000-E1006
6. Miles JM, Ellman MG, McClean KL, Jensen MD (1987) Validation of a new method for determination of free fatty acid turnover. Am J Physiol Endocrinol Metab 252:E431-E438
7. Nielsen S, Guo Z, Albu JB, Klein S, O'Brien PC, Jensen MD (2003) Energy expenditure, sex, and endogenous fuel availability in humans. J Clin Invest 111:981-988
8. Havel RJ, Carlson LA, Ekelund L, Holmgren A (1964) Turnover rate and oxidation of different free fatty acids in man during exercise. J Appl Physiol 19:613-618
9. Roust LR, Jensen MD (1993) Postprandial free fatty acid kinetics are abnormal in upper body obesity. Diabetes 42:1567-1573
10. Kelley DE, Mokan M, Simoneau JA, Mandarino LJ (1993) Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91-98
11. Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
12. Rebrin K, Steil GM, Mittelman SD, Bergman RN (1996) Casual linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs. J Clin Invest 98:741-749
13. Lewis GF, Uffelman KD, Szeto LW, Weller B, Steiner G (1995) Interaction between free fatty acids and insulin in the acute control of very low density lipoprotein production in humans. J Clin Invest 95:158-166
14. Steinberg HO, Tarshoby M, Monestel R et al (1997) Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation. J Clin Invest 100:1230-1239
15. Kanaley JA, Andresen-Reid ML, Oenning L, Kottke BA, Jensen MD (1993) Differential health benefits of weight loss in upper-body and lower-body obese women. Am J Clin Nutr 57:20-26
16. Miyazaki Y, Mahankali A, Matsuda M, Mahankali S, Hardies J, Cusi K et al (2002) Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. J Clin Endocrinol Metab 87:2784-2791
17. Miles JM, Wooldridge D, Grellner WJ et al (2003) Nocturnal and postprandial free fatty acid kinetics in normal and type 2 diabetic subjects: effects of insulin sensitization therapy. Diabetes 52:675-681
18. Boden G, Cheung P, Mozzoli M, Fried SK (2003) Effect of thiazolidinediones on glucose and fatty acid metabolism in patients with type 2 diabetes. Metabolism 52:753-759
19. Mayerson AB, Hundal RS, Dufour S et al (2002) The effects of rosiglitazone on insulin sensitivity, lipolysis, and hepatic and skeletal muscle triglyceride contents in patients with type 2 diabetes. Diabetes 51:797-802
20. Racette SB, Davis AO, McGill JB, Klein S (2002) Thiazolidinediones enhance insulin-mediated suppression of fatty acid flux in type 2 diabetes mellitus. Metabolism 51:169-174
21. Firth RG, Bell PM, Rizza RA (1986) Effects of tolazamide and exogenous insulin on insulin action in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 314:1280-1286
22. Botion LM, Green A (1999) Long-term regulation of lipolysis and hormone-sensitive lipase by insulin and glucose. Diabetes 48:1691-1697
23. Smith U (1974) Studies of human adipose tissue in culture: III. Influence of insulin and medium glucose concentration on cellular metabolism. J Clin Invest 53:91-98
24. Shadid S, Jensen MD (2003) Effects of pioglitazone vs diet and exercise on metabolic health and fat distribution in upper body obesity. Diabetes Care 26:3148-3152
25. Shadid S, Jensen MD (2002) Angioneurotic edema as a side effect of pioglitazone. Diabetes Care 25:405
26. Brownell KD (2002) The LEARN program for weight management 2000. American Health Publishing Company, Dallas
27. 2]-D-glucose-enriched plasma samples by gas chromatography-mass spectrometry. J Chromatogr 572:302-306
28. Causon RC, Carruthers ME, Rodnight R (1981) Assay of plasma catecholamines by liquid chromatography with electrochemical detection. Anal Biochem 116:223-226
29. Humphreys SM, Fisher RM, Frayn KN (1990) Micromethod for measurement of sub-nanomole amounts of triacylglycerol. Ann Clin Biochem 27:597-598
30. Folch J, Lees M, Sloane Stanley GH (1957) A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 226:497-509
31. Jensen MD (1995) Gender differences in regional fatty acid metabolism before and after meal ingestion. J Clin Invest 96:2297-2303
32. Tanner JM (1949) Fallacy of per-weight and per-surface area standards, and their relation to spurious correlation. J Appl Physiol 2:1-15
33. Coon PJ, Rogus EM, Drinkwater DT, Muller DC, Goldberg AP (1992) Role of body fat distribution in the decline in insulin sensitivity and glucose tolerance with age. J Clin Endocrinol Metab 75:1125-1132
34. Tiikkainen M, Häkkinen A-M, Korsheninnikova E, Nyman T, Mäkimattila S, Yki-Jarvinen H (2004) Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 53:2169-2176
35. Hevener AL, Reichart D, Janez A, Olefsky J (2001) Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male Wistar rats. Diabetes 50:2316-2322
36. Jensen MD, Chandramouli V, Schumann WE et al (2001) Sources of blood glycerol during fasting. Am J Physiol Endocrinol Metab 281:E998-E1004
37. Jensen MD, Caruso M, Heiling V, Miles JM (1989) Insulin regulation of lipolysis in nondiabetic and IDDM subjects. Diabetes 38:1595-1601
38. Jensen MD (1991) Regulation of forearm lipolysis in different types of obesity. In vivo evidence for adipocyte heterogeneity. J Clin Invest 87:187-193
39. Guo ZK, Hensrud DD, Johnson CM, Jensen MD (1999) Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 48:1586-1592
40. Rebrin K, Steil GM, Getty L, Bergman RN (1995) Free fatty acids as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 44:1038-1045
41. Coppack SW, Evans RD, Fisher RM et al (1992) Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism 41:264-272
42. Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV (1970) Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest 49: 2017-2035
43. Nagashima K, Lopez C, Donovan D et al (2005) Effects of the PPARγ agonist pioglitazone on lipoprotein metabolism in patients with type 2 diabetes mellitus. J Clin Invest 115:1323-1332
44. Coppack SW, Persson M, Judd RL, Miles JM (1999) Glycerol and nonesterified fatty acid metabolism in human muscle and adipose tissue in vivo. Am J Physiol Endocrinol Metab 276: E233-E240
45. Dea MK, Van Citters GW, Ader M, Mittelman SD, Sunehag AL, Bergman RN (2000) Paradoxical effect of troglitazone in normal animals: enhancement of adipocyte by reduction of liver insulin sensitivity. Diabetes 49:2087-2093